Breaking news from “The Pink Sheet” DAILY
Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including the FDA Antiviral Drugs Advisory Committee's approval recommendation for Bristol's Baraclude (entecavir) for treatment of chronic hepatitis B infection and a Crestor "untitled" letter. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...
You may also be interested in...
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.